Beth Zelnick - Dec 12, 2024 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Chief Legal Officer
Signature
/s/ Beth Zelnick Kaufman
Stock symbol
CRMD
Transactions as of
Dec 12, 2024
Transactions value $
-$53,006
Form type
4
Date filed
12/16/2024, 04:15 PM
Previous filing
Dec 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Options Exercise +12.5K +25% 62.5K Dec 12, 2024 Direct F1
transaction CRMD Common Stock Tax liability -$53K -6.04K -9.67% $8.77 56.5K Dec 12, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Restricted Stock Units Options Exercise $0 -12.5K -25% $0.00 37.5K Dec 12, 2024 Common Stock 12.5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 These Restricted Stock Units were granted on 12/12/2023 and vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.